Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
07/2004
07/01/2004WO2004055006A1 Novel compounds having selective inhibiting effect at gsk3
07/01/2004WO2004055002A1 Carbazole derivatives and their use as npy-5 antagonists
07/01/2004WO2004054987A1 Cathepsin cysteine protease inhibitors and their use
07/01/2004WO2004054986A2 Process for the preparation of pyrimidine compounds
07/01/2004WO2004054984A1 4-substituted benzimidazoles and their use as inhibitors of gastric secretion
07/01/2004WO2004054624A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands
07/01/2004WO2004054617A1 Preventives and/or remedies for central diseases
07/01/2004WO2004054584A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists
07/01/2004WO2004054498A2 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
07/01/2004WO2004039774A3 Mitotic kinesin inhibitors
07/01/2004WO2004026237A3 Compounds for the treatment of premature ejaculation
07/01/2004WO2004018058A3 Compounds, compositions, and methods
07/01/2004WO2004016086B1 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
07/01/2004WO2003093297A3 Protein kinase modulators and methods of use
07/01/2004WO2003080577A3 Amidoacetonitrile compounds
07/01/2004US20040127733 adrenergic blocking agents; for treatment of diabetes/obesity
07/01/2004US20040127708 antiviral activities; aids treatment
07/01/2004US20040127707 Novel phthalazinones
07/01/2004US20040127689 activated haptens useful for generating immunogens to HIV protease inhibitors
07/01/2004US20040127544 Mannich base prodrugs of 3-(Pyrrol-2-yl-methylidene)-2-indolinone derivatives
07/01/2004US20040127542 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
07/01/2004US20040127536 Indazole Derivatives
07/01/2004US20040127530 treating gram-negative microbial infections
07/01/2004US20040127528 Metalloproteinase inhibitors
07/01/2004US20040127527 Large conductance calcium-activated k channel opener
07/01/2004US20040127518 For therapy of anxiety or pain, and other neurological, sleep, or psychological disorders, for inducing sleep, for treating glaucoma, and controlling appetite or appetive disorders
07/01/2004US20040127515 For therapy of hypertension, chronic obstructive pulmonary disease, organ damage, pain, diabetic nephropathy, dementia
07/01/2004US20040127507 Imidazolidine compounds
07/01/2004US20040127504 Administering benzimidazole compound for therapy of sexual dysfunction in a mammal
07/01/2004US20040127502 Use of pyrimidine compound galanin receptor subtype 3 (GAL3) antagonists, which may be classified as neutral antagonists, inverse agonists or allosteric modulators, to treat depressive disorders and/or anxiety
07/01/2004US20040127501 Therapeutic agents useful for treating pain
07/01/2004US20040127492 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2
07/01/2004US20040127484 Novel bicyclic inhibitors of hormone sensitive lipase
07/01/2004US20040127477 Heterocyclic glycyl beta-alanine derivatives
07/01/2004US20040123400 Human hair; using mixture of dye with oxidizer and coupler
07/01/2004DE10260730A1 Neue substituierte stickstoffhaltige Heterobicyclen, deren Herstellung und deren Verwendung als Arzneimittel New substituted nitrogen containing heterobicycles, their preparation and their use as medicaments
07/01/2004DE10259407A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis
07/01/2004CA2549463A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands
07/01/2004CA2510683A1 Carbazole derivatives and their use as npy-5 antagonists
07/01/2004CA2508838A1 4-substituted benzimidazoles and their use as inhibitors of gastric secretion
07/01/2004CA2508045A1 Novel compounds having selective inhibiting efect at gsk3
07/01/2004CA2507425A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists
06/2004
06/30/2004EP1433479A1 Appetite-stimulating agents and remedies for anorexia
06/30/2004EP1432699A1 Pyridylfurans and pyrroles as raf kinase inhibitors
06/30/2004EP1432693A2 Mch receptor antagonists
06/30/2004EP1432692A1 Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them
06/30/2004EP1432691A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
06/30/2004EP1432690A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
06/30/2004EP1432689A1 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders
06/30/2004EP1432687A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
06/30/2004EP1432421A1 Quinoline derivatives as neuropeptide y antagonists
06/30/2004EP1432417A2 Substituted benzimidazole compounds and their use for the treatment of cancer
06/30/2004EP1432416A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
06/30/2004EP1037880B1 Retinoic acid mimetic anilides
06/30/2004CN1509286A Metalloproteinase inhibitors
06/30/2004CN1509285A Substituted aryl ketons
06/30/2004CN1509284A Delta1 pyrrolines
06/30/2004CN1509276A Metalloproteinase inhibitors
06/30/2004CN1509275A Metalloproteinase inhibitors
06/30/2004CN1509274A Metallo proteinase inhibitors
06/30/2004CN1509273A Metalloproteinase inhibitors
06/30/2004CN1509272A Metalloproteinase inhibitors
06/30/2004CN1509270A Indolinons, substituted in position 6, and their preparation and use as kinase inhibitors
06/30/2004CN1509196A 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor
06/30/2004CN1155596C New phenylpiperazines
06/30/2004CN1155595C Substituted pyrroles as antiproliferative agents for treatment of cancer
06/30/2004CN1155594C Polymorphic salt as medicine for migraine
06/30/2004CN1155572C Indole derivatives and its anticancer usage
06/30/2004CN1155570C Novel cyano-indole serotonin reextracted inhibitor compound, its preparation process and medicinal compositions having same
06/30/2004CN1155569C Indolin derivs. as sun protection agents
06/30/2004CN1155567C Antipsychotic indolyl derivatives
06/30/2004CN1155312C Herbicidal synergic composition and method for controlling weed
06/30/2004CN1155311C Herbicidal synergic composition and method for controlling weed
06/29/2004US6756397 Such as (s)-n-(2-((1-chloromethyl)-1,2-dihydro-5-((4-methylpiperazino)carbonyloxy) -3h-benz(e) indol-3-yl)carbonyl)-1h-indol-5-yl)-5-((3-methyldithio-1-oxopropyl)-amino) -1h-indole-2-carboxamide; enhanced water solubility and stability
06/29/2004US6756394 Small molecule inhibitors of necrosis
06/29/2004US6756391 Antiviral compounds
06/29/2004US6756386 Such as 1-methyl-3-oxy-(5-chloro-3-pyridyl)-piperidine; cholinergic system of central nervous system; pain, inflammation
06/29/2004US6756385 Imidazole derivatives
06/29/2004US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis
06/29/2004US6756367 Useful in the treatment of any state with increased endogenous level of corticotropin releasing hormone(crf) or hpa (hypothalamic pituitary axis) is disregulated or diseases induced by crf, including inflammatory disorders, anxiety etc
06/29/2004CA2205384C Dihydropyrimidines and uses thereof
06/24/2004WO2004052870A1 Triazine compounds and their use in forming multidimensional libraries for affinity chromatography
06/24/2004WO2004052869A1 5-substituted-pyrazine or pyridine glucokinase activators
06/24/2004WO2004052868A1 Pyrazine-based tubulin inhibitors
06/24/2004WO2004052866A1 3-phenyl-cinnoline homologue and antitumor agent containing the same
06/24/2004WO2004052864A1 Pyrazole and imidazole compounds and uses thereof
06/24/2004WO2004052862A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
06/24/2004WO2004052856A1 Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
06/24/2004WO2004052852A1 3-pyrrolyl urea derivatives and their use as antiviral agents
06/24/2004WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators
06/24/2004WO2004052304A2 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif
06/24/2004WO2004052280A2 Anti-angiogenic compounds and their use in cancer treatment
06/24/2004WO2004005288A3 Charge transport compositions comprising fluorinated phenanthroline derivatives
06/24/2004WO2003099221A3 Methods for using jnk inhibitors for treating or preventing disease-related wasting
06/24/2004WO2003094839A8 Pyrimidinone compounds, compositions and methods
06/24/2004WO2003090690A3 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
06/24/2004WO2003072056A3 Intranasal administration of mc4-r agonists
06/24/2004WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/24/2004US20040122238 for color photography
06/24/2004US20040122234 Growth Hormone secretagogues